From October 27, 2023 to December 31, 2023, the company has repurchased 1,814,653 shares, representing 3.1% for $49.99 million. With this, the company has completed the repurchase of 1,814,653 shares, representing 3.1% for $49.99 million under the buyback announced on October 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.4 USD | +1.69% | -1.84% | -8.98% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.98% | 1.67B | |
+40.73% | 739B | |
+31.69% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.45% | 240B | |
+9.23% | 210B | |
-5.19% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Tranche Update on Harmony Biosciences Holdings, Inc.'s Equity Buyback Plan announced on October 31, 2023.